ACOG Alpha Cognition Inc.

NASDAQ
$7.83

Alpha Cognition Inc. (ACOG) is expected to report earnings on February 10, 2027, after the market close. The consensus earnings estimate is a loss of $0.29 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -9.2% since its last earnings release on November 11, 2026.

Alpha Cognition Beat Consensus Estimates
Wednesday, November 11, 2026 · 4:05 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 10
Wednesday · 4:05 PM ET
Earnings Whisper
-
vs ($0.29)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $8.19

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Alpha Cognition Inc.

Alpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease and Cognitive Impairment with mild Traumatic Brain Injury (“mTBI”), for which there are currently no approved treatment options.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.